UCB recently announced availability of NAYZILAM® (midazolam) Nasal Spray CIV in retail pharmacies. NAYZILAM is the first and only nasal rescue treatment for seizure clusters in the U.S. It is a ready-to-use solution that can be used when and where a seizure cluster occurs and can be administered by non-healthcare professionals to people 12 years and older. Copay support and a patient assistance program is available for eligible patients.
Its nasal delivery could provide significant value to patients who currently have limited treatment options. Speak to your healthcare provider to learn if NAYZILAM® has the potential to improve the life and safety of your loved one with Dravet syndrome by providing another option for rescue care.
For more information, read the full press release here.